Healthcare SaaS Solutions Market

The healthcare SaaS solutions market is worth USD 32,760.0 million in 2025 and reaches USD 109,107.2 million by 2035, compounding at 12.78% a year. The figure is built bottom-up: roughly 420,000 healthcare organisations paying for software as a service in 2025 across clinical and electronic health record SaaS, revenue cycle and financial SaaS, life sciences and clinical research SaaS, and patient engagement, analytics and artificial intelligence SaaS, at an average annual contract value of USD 78,000 per organisation, triangulated against healthcare organisation counts, software vendor disclosures and IT spending data. Paying organisations grow 6.0% a year as providers, payers and life sciences companies move from on-premise software to the cloud, while contract value rises 6.4% a year as customers add modules and artificial intelligence features. Telehealth visit services, pharmaceutical serialisation software covered in our separate serialisation coverage, and on-premise software licences are excluded. This study sits within our healthcare IT coverage and follows the published Douglas Insights methodology.

Why did healthcare move to the cloud so late?

Because healthcare handles some of the most sensitive data in any industry, runs critical systems that cannot go down, and relied for decades on large software installations inside hospital data centres, all of which made organisations cautious about moving. Hospitals traditionally bought electronic health record and administrative systems as licences, ran them on their own servers, and paid for maintenance. Concerns about patient privacy, regulatory compliance and control kept many organisations on premise long after other industries had adopted cloud software. That has changed over the past decade. Vendors now offer secure cloud and hosted versions of core systems, cloud providers offer compliance with health data rules, and the cost and difficulty of running complex software in house, especially as cyberattacks grow, has pushed organisations toward subscription services. Life sciences companies moved earlier, adopting cloud platforms for clinical trials and commercial operations. The shift is now broad, and subscription revenue is replacing licence revenue across healthcare software. The exclusive chapter of this report tracks cloud migration by segment and region, since migration drives much of the growth.

What does this market include?

This study covers software delivered as a subscription service to healthcare providers, payers and life sciences organisations. Clinical and electronic health record SaaS covers cloud based health records, clinical documentation, practice management and departmental clinical systems. Revenue cycle and financial SaaS covers billing, claims, coding, payment and financial management software for providers and payers. Life sciences and clinical research SaaS covers software for clinical trials, regulatory submissions, quality and commercial operations for pharmaceutical and medical device companies. Patient engagement, analytics and artificial intelligence SaaS covers patient portals and communication, population health analytics, and artificial intelligence tools such as ambient clinical documentation. Telehealth visit services and fees, pharmaceutical serialisation and track-and-trace software, on-premise licences and maintenance, IT services and consulting, and medical device software sold with hardware sit outside the boundary. Value is measured at subscription revenue.

What is AI adding to healthcare software?

Artificial intelligence is becoming a paid add-on across healthcare software, and the fastest early adoption has been in tools that reduce the documentation burden on clinicians. Ambient clinical documentation listens to conversations between clinicians and patients and drafts clinical notes automatically, saving doctors time spent typing after consultations, and it has been adopted quickly by many health systems because clinician burnout from paperwork is a serious problem. Artificial intelligence is also being applied to coding and billing, prior authorisation, message handling, scheduling and clinical decision support. For software vendors, these features raise contract values and create new products. For buyers, the questions are accuracy, liability and cost. The model treats artificial intelligence modules as a major contributor to rising contract values over the forecast.

What drives demand?

The first driver is cloud migration. Providers, payers and life sciences companies are moving core systems from on-premise installations to subscription services, and most of those systems run on the managed databases analysed in our Relational Databases Software Market report.

The second driver is cost and workforce pressure. Healthcare organisations use software to automate administration, reduce clinician workload and manage costs.

The third driver is artificial intelligence. New artificial intelligence tools, particularly for documentation, add paid modules to existing subscriptions.

The fourth driver is value based care and data. Payment models that reward outcomes require analytics and population health software.

What restrains the market?

Three restraints are modelled. Security and resilience are the first: cyberattacks on healthcare organisations and software vendors, including major disruptions to claims processing, highlight the risk of relying on a few cloud platforms. Budget pressure is second: hospitals and health systems face tight finances, which can delay software purchases. Regulation and interoperability are third: health data privacy rules and requirements for data exchange add complexity and cost.

Which categories carry the value?

Clinical and electronic health record SaaS leads with 30% of 2025 value, USD 9,828.0 million. Revenue cycle and financial SaaS holds 26%, USD 8,517.6 million. Life sciences and clinical research SaaS accounts for 22%, USD 7,207.2 million, and patient engagement, analytics and artificial intelligence SaaS 22%, USD 7,207.2 million, the latter growing fastest. Each category is modelled through 2035 by region.

Where is healthcare SaaS used?

North America dominates with 62% of 2025 value, USD 20,311.2 million, growing 11.93% a year, reflecting the size of United States healthcare spending, its complex billing system and early adoption of cloud and artificial intelligence tools. Europe holds 20%, USD 6,552.0 million, at 13.0%, as public health systems digitise. Asia Pacific holds 13%, USD 4,258.8 million, and grows fastest at 15.6%, with digital health investment in China, India, Japan and Australia. The Middle East contributes USD 786.2 million at 14.4%, Latin America USD 655.2 million at 13.6% and Africa USD 196.6 million at 13.0%. Six regional models sum to the global figure, with country tables in the Excel model.

Who provides healthcare SaaS?

Electronic health record vendors such as Epic, Oracle Health and athenahealth provide cloud and hosted clinical platforms. Veeva Systems and Medidata, part of Dassault Systèmes, lead in life sciences software. Revenue cycle software is supplied by companies such as R1, Waystar and Optum. Artificial intelligence documentation is provided by Microsoft’s Nuance, Abridge and others, and cloud providers supply infrastructure and platforms. The competitive chapter profiles leading vendors by segment and region.

How is healthcare SaaS priced?

Average annual contract value is USD 78,000 per organisation in 2025, masking a vast range from small practices paying a few thousand dollars a year to large health systems and pharmaceutical companies paying millions. Pricing is typically per user, per provider, per bed, per transaction or as a percentage of collections for revenue cycle services. Contract values rise as organisations add modules and artificial intelligence features. The pricing chapter publishes pricing models and bands by segment.

How do the scenarios diverge by 2035?

The base case carries 6.0% growth in paying organisations and 6.4% growth in contract value for a 12.78% revenue CAGR and USD 109,107.2 million in 2035. The budget-squeeze scenario, in which healthcare finances tighten and security concerns slow migration, sets the legs at 3.8% and 4.4%, landing near USD 73,160 million. The AI-acceleration scenario, in which artificial intelligence tools are adopted widely and migration speeds up, sets them at 7.6% and 8.0%, carrying the market past USD 147,140 million. Each 1-point change in organisation growth moves the 2035 figure by roughly USD 10,290 million.

Which rules and standards apply?

Three layers matter. Health data privacy and security rules come first: laws governing the protection of health information set requirements for software vendors and their customers. Interoperability rules are second: regulations requiring health data exchange and patient access to records shape software design. Regulation of software as a medical device and artificial intelligence is third: some clinical software and artificial intelligence tools are regulated as medical devices, and artificial intelligence rules are developing. The regulatory chapter maps these requirements by jurisdiction.

How concentrated is the risk?

As healthcare moves onto shared cloud platforms, disruption at a single vendor can affect vast numbers of organisations at once, as a major cyberattack on a large claims processing company demonstrated when it disrupted payments to providers across the United States for weeks. Such incidents push buyers to demand stronger security, backup arrangements and contractual protections, and push regulators toward stricter oversight of critical healthcare vendors. They do not reverse the move to the cloud, but they add cost and slow some decisions. The model reflects concentration risk in the downside scenario.

Douglas Exclusive: the cloud migration tracker

This report tracks, by segment and region, the share of healthcare organisations using cloud versus on-premise software, migration plans, contract values and artificial intelligence module adoption, converting healthcare organisation counts into subscription revenue by category and region. Licence holders receive it as a maintained tab in the Excel model.

Methodology and receipts

The model is built bottom-up from paying organisations: healthcare providers, payers and life sciences companies by size and region, SaaS adoption rates by category, annual contract values, and realised subscription revenue from vendor disclosures, with telehealth visit services, serialisation software, on-premise licences, IT services and device software excluded. Every figure carries a numbered source and a confidence grade in the fact sheet above, and the working model ships with every licence. The next scheduled review of this study is September 2027.